The combined treatment of HMGB1 and GEM with RSL3 significantly suppressed tumor proliferation in in vivo experiments (Fig. 5H, Fig. S5C, D), immunohistochemistry also confirmed this result (Fig. 5I). This evidence concerns the gene HMGB1 and neoplasm.